Alpha Teknova, Inc. Stock

Equities

TKNO

US02080L1026

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:30:00 2024-05-02 EDT 5-day change 1st Jan Change
1.935 USD +1.31% Intraday chart for Alpha Teknova, Inc. +13.82% -48.12%
Sales 2024 * 38.71M 52.89M Sales 2025 * 46M 62.86M Capitalization 78.99M 108M
Net income 2024 * -27M -36.89M Net income 2025 * -24M -32.79M EV / Sales 2024 * 2.04 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.72 x
P/E ratio 2024 *
-2.39 x
P/E ratio 2025 *
-3.77 x
Employees 211
Yield 2024 *
-
Yield 2025 *
-
Free-Float 25.81%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.31%
1 week+13.82%
Current month+8.71%
1 month-22.60%
3 months-42.07%
6 months-3.25%
Current year-48.12%
More quotes
1 week
1.68
Extreme 1.68
1.95
1 month
1.68
Extreme 1.68
2.63
Current year
1.68
Extreme 1.68
4.18
1 year
1.62
Extreme 1.62
4.27
3 years
1.62
Extreme 1.62
30.89
5 years
1.62
Extreme 1.62
30.89
10 years
1.62
Extreme 1.62
30.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 45 20-04-30
Director of Finance/CFO 53 21-01-31
Chief Tech/Sci/R&D Officer - 20-04-30
Members of the board TitleAgeSince
Director/Board Member 68 18-12-31
Director/Board Member 64 21-05-31
Director/Board Member 71 23-08-30
More insiders
Date Price Change Volume
24-05-02 1.935 +1.31% 10,382
24-05-01 1.91 +7.30% 5,458
24-04-30 1.78 +4.71% 26,057
24-04-29 1.7 -1.73% 10,959
24-04-26 1.73 +1.76% 23,753

Delayed Quote Nasdaq, May 02, 2024 at 04:30 pm

More quotes
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.935 USD
Average target price
5.5 USD
Spread / Average Target
+184.24%
Consensus